comprehensive -WSS

comprehensive

author：focus 2025-10-01 10:33:34 - browse：37795

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Elon Musk announces 'temporary limits' for reading Twitter posts

explore

WSS

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Flu, Covid vaccination rates decline, new survey data show

Leon Gautier, last member of French D

Lawsuit highlights wrinkle for disputes over surprise medical bills

4 dead, 2 in stable condition in Philadelphia shooting: Police

Congress extends some pandemic preparedness programs

knowledge

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

Will an HIV vaccine ever be a reality?

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NASA releases new images of 'fingerprint

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

RSV injection headlines need to be accurate for good uptake

At least 13 dead in Texas as scorching temps continue

The Karikó problem: Lessons for funding basic research

focus

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

WHO recommends second malaria vaccine

Setback for rare diseases as Taysha Gene Therapies pulls back

IVG is promising — but it won’t replace IVF quite yet

What we owe ALS patients — and why one company fell short

Greece's new parliament sworn in following conservative party's election victory

hotspot

explore

hotspot

focus